Parliamentary Search

Written question asked by Julian Lewis (Conservative) on Friday, 20 February 2026, in the House of Commons. It was due for an answer on Wednesday, 25 February 2026 (named day). A holding answer was provided on Thursday, 26 February 2026. A substantive answer was provided by Sharon Hodgson (Labour) on Monday, 16 March 2026 on behalf of the Department of Health and Social Care.

Naloxone

Question

To ask the Secretary of State for Health and Social Care, if he will take steps to increase awareness of naloxone as an effective emergency treatment among (a) people at risk of opioid overdose and (b) people who may witness an opioid overdose.

Answer

Naloxone forms a key part of the Government’s plan to reduce drug‑related deaths, and we are committed to raising awareness of, and expanding access to, naloxone across the country.

In 2024, the Government amended the Human Medicines Regulations 2012. This legislation enables more services and professionals to supply naloxone, which in turn makes it easier for people at risk, and those close to them, to access it. We are continuing to work with the other United Kingdom nations and front-line services to ensure naloxone reaches all those who need it.

In addition to the changes made in 2024 to expand access, we recently launched a ten-week UK-wide public consultation on further legislative options to expand access to take-home and emergency use naloxone.

Increasing awareness of naloxone, and ensuring frontline services are trained to use it, is vital to reducing deaths from opioid overdoses. Last year, the Department published guidance on the GOV.UK website that sets out essential practical information such as who can supply naloxone, the products available, how to use naloxone and other basic lifesaving tools, and the training required.

Secondary information

Type
Written question
Reference
113436
Session
2024-26
Subjects
Medical treatments Opioids Overdoses Naloxone
Link
View this Written question on www.parliament.uk